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Relationship between dyslipidaemia and glycaemic status in patients with type 2 
diabetes mellitus  
ABSTRACT 
The risk of coronary heart disease (CHD) is dramatically increased in diabetic patients due to 
their atherogenic lipid profile. The  severity  of  CHD  in  diabetic  patients  has  been  found  
to  be  directly  associated  with  glycated  haemoglobin  (HbA1c).  According to the 
Malaysian Clinical Practice Guidelines on diabetes mellitus (DM), HbA1c level less than 
6.5% reduces the risk of microvascular and macro vascular complications.  Hence,  this  
study  aimed  to  determine  the  relationship  between dyslipidaemia  and  glycaemic  status  
in  patients  with  type  2  DM  (T2DM)  patients  in  Hospital  Putrajaya, a tertiary endocrine 
centre in Malaysia. This was a cross sectional, retrospective study of 214 T2DM patients with 
dyslipidaemia who had visited the endocrine clinic between January 2009 and December 
2012. Significant correlations were found between fasting blood glucose (FBG) and HbA1c  
with  total  cholesterol  (TC),  triglyceride  (TG),  low  density  lipoprotein  cholesterol  
(LDL), non-high  density  lipoprotein  cholesterol  (non-HDL),  LDL/HDL  ratio  and  
TC/HDL  ratio;  greater  correlation being with HbA1c than FBG. In patients with HbA1c 
≥6.5%, TC, TG, non-HDL and TC/HDL ratio were significantly higher than in patients with 
HbA1c < 6.5%. Non-HDL, LDL/HDL ratio, TC/HDL ratio and HbA1c were significantly 
lower in patients on statin treatment than non-treated patients (p<0.05).  This significant 
association between glycaemic status and dyslipidaemia emphasises  the  additional  possible  
use  of  HbA1c  as  a  biomarker  for  dyslipidaemia  as  well  as  a  potential indirect 
predictor of cardiovascular disease (CVD) risk in T2DM patients.  
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